Changzhou Qianhong Biopharma CO.,LTD
002550.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.79B
Close$
$4.68
25.4% downside
Current Fair Value
25.4% downsideOvervalued by 25.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.79 Billion |
|---|---|
| Enterprise Value | $7.47 Billion |
| Dividend Yield | $0.15 (2.39%) |
| Earnings per Share | $0.32 |
| Beta | 0.04 |
| Outstanding Shares | 1,242,800,000 |
Return
| Return on Equity | 10.72% |
|---|---|
| Return on Assets | 9.38% |
| Return on Invested Capital | 11.45% |
Valuation & Multiples
| P/E Ratio | 26.7 |
|---|---|
| PEG | -88.44 |
| Price to Sales | 6.27 |
| Price to Book Ratio | 3.14 |
| Enterprise Value to Revenue | 5.09 |
| Enterprise Value to EBIT | 23.07 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Changzhou Qianhong Biopharma CO.,LTD
1,038 employees
CEO: Ke Wang Changzhou Qianhong Biopharma CO.,LTD operates as a key player in China's biopharmaceutical sector, specializing in the research, development, production, and distribution of biological drugs, with a core focus on enzyme and polysaccharid...